Scandinavian ChemoTech
1,03
SEK
+0,98 %
CMOTEC B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Mindre end 1K følgere
+0,98%
-37,95%
-42,46%
-44,32%
-42,13%
-65,08%
-92,76%
-90,28%
-97,27%
Scandinavian ChemoTech is a research and development company that has developed the technology Tumor-Specific Electroporation - TSE ™ for the treatment of various cancers. The technology means that electronic pulses are sent to the treated area and the membranes of the tumor cells are opened to reach their DNA. In addition to its operations in Sweden, the company is also active in Southeast Asia and India. Scandinavian ChemoTech was founded in 2015 and is headquartered in Lund.
Læs mereMarkedsværdi
24,04 mio. SEK
Aktieomsætning
57,75 t SEK
Omsætning
2,82 mio.
EBIT %
-717,73 %
P/E
-
Udbytteafkast, %
-
Finanskalender
4.3
2025
Årsrapport '24
6.5
2025
Delårsrapport Q1'25
13.5
2025
Generalforsamling '25
ViserAlle indholdstyper
ChemoTech: Scandinavian ChemTech's Animal Care operations showed positive cashflow for 2024 in separate reporting
ChemoTech: Latest News: New Website for TSE - A Potential New Paradigm in Cancer Care
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools